2 November 2020 Oryzon announces appointment of Dr. Torsten Hoffmann as Global R&D Director and retirement of Dr. Tamara Maes
26 October 2020 ORYZON Reports Results for Quarter Ended September 30, 2020 and Provides Corporate Update
15 October 2020 ORYZON publishes paper in Journal of Clinical Oncology demonstrating relevance of iadademstat in leukemia
17 September 2020 ORYZON presents efficacy and safety results of its CLEPSIDRA trial with iadademstat in ED-SCLC patients at ESMO-2020
27 July 2020 ORYZON presents vafidemstat clinical data from its Phase IIa clinical trial ETHERAL in Alzheimer’s at the virtual AAIC-2020 conference
6 July 2020 ORYZON presents final data from its Phase IIa clinical trial REIMAGINE at the 28th European Congress of Psychiatry, EPA 2020